Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice their appetite beginning to change within the first week or two of starting Mounjaro, though visible weight loss typically becomes measurable after four to eight weeks. The full picture takes longer: in SURMOUNT-1, published in the New England Journal of Medicine, participants using tirzepatide lost an average of around 20% of their body weight over 72 weeks — a gradual, sustained process rather than a dramatic early drop. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it is a Tuesday morning, you have just taken your second Mounjaro pen from the fridge door and you are wondering whether it is working at all. That is a common point of doubt, and it is worth understanding what is actually happening.
The 2.5mg starting dose exists to let your body adjust to the medicine, not to deliver the weight loss you will eventually see at higher doses. Gastric emptying slows, hunger signals quieten, and many people eat noticeably less without feeling deprived. But the scale may barely shift. That is not a failure; that is the medicine working as designed.
Nausea, if it appears, tends to peak in this early window. It is usually mild and temporary, and often means the medicine is doing exactly what it should. If side effects are bothering you, the right conversation is with your prescriber, not a dose adjustment you decide on independently.
If you are curious about how soon you can expect to lose weight on Mounjaro, it helps to know that some people do see a meaningful number move on the scale before week four, while others do not, and both experiences sit within normal.
Once doses begin increasing, typically in four-week steps as the prescriber directs, the effect on appetite and weight tends to compound. This is the phase that shows up in the trial data most clearly.
In SURMOUNT-1, participants had lost roughly 10% of body weight by week 24 on average at the higher doses, and they were still losing. The trajectory matters as much as any single number: Mounjaro produces a gradual, sustained reduction rather than a sharp early loss that plateaus.
It is also worth understanding that the dose you are on directly influences your results. Someone still at 5mg at month three will have a different curve to someone who has reached 10mg. Titration pace is a clinical decision, shaped by how you are tolerating the medicine and your health history. You can read more about how the drug works mechanically on the tirzepatide overview page.
Lifestyle sits alongside the medicine, not in competition with it, and understanding how to lose weight on Mounjaro covers how protein adequacy, hydration and some form of activity all support the process, though your prescriber or a dietitian is better placed than any article to advise on specifics.
The headline figures from clinical research (average losses of around 20% of body weight at 15mg) were measured at 72 weeks. That is over a year of treatment at the highest maintenance dose. Framing those numbers against a six-week timeline misreads the evidence.
The NHS tirzepatide information page confirms that Mounjaro is licensed for weight management alongside a reduced-calorie diet and increased activity, and notes that results vary between individuals. There is no version of this medicine that bypasses the gradual physiology.
People who lose weight most consistently over this longer window tend to be those who stay on the highest dose they can tolerate, maintain some dietary awareness, and have clinical support when questions arise. The practical steps that support better outcomes on Mounjaro are worth exploring if you are already on treatment and want to make the most of it.
If you are weighing up what kind of result is realistic for your starting point, the question of whether Mounjaro will work for you specifically goes deeper into the individual factors involved.
Starting weight plays a role: someone with more to lose often sees a larger absolute drop early on, while the percentage figure may look similar to someone lighter. Metabolic rate, medication interactions, sleep and stress all have documented effects on how the body responds to a GLP-1/GIP medicine.
Reaching the dose that works for you is not always a straight path. Some people settle at 7.5mg or 10mg rather than 15mg, either because side effects warrant it or because clinical review shows that is the right level. A lower maintenance dose still produces meaningful weight loss, just typically a smaller percentage than the trial's 15mg arm.
If you are comparing Mounjaro to other options, the weight loss treatment overview covers the licensed landscape honestly. And if the question of cost is in the back of your mind, the Mounjaro pricing page sets out what private treatment typically involves without any of the hidden fees that can make a headline price misleading.
Mounjaro is a prescription-only medicine and every decision about your dose, your pace and your plan belongs in a clinical conversation. If you are ready to start that conversation, speak to our prescribers, a GPhC-registered Independent Prescriber reviews every consultation personally, and there are no referrals or waiting lists involved.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.